Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance

NCT02928614 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis
Obesity

Interventions

DRUG: Liraglutide 3 mg (Saxenda)
DRUG: Liraglutide 3 mg placebo

Sponsor

Henrik Gudbergsen